ReviewSome Considerations in Choosing Electroconvulsive Therapy Versus Transcranial Magnetic Stimulation for DepressionRasmussen, Keith G. MD Author Information From the Department of Psychiatry, Mayo Clinic, Rochester, MN. Received for publication January 7, 2010; accepted February 11, 2010. Reprints: Keith G. Rasmussen, MD, Department of Psychiatry, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (e-mail: [email protected]). The Journal of ECT: March 2011 - Volume 27 - Issue 1 - p 51-54 doi: 10.1097/YCT.0b013e3181da84c6 Buy Metrics Abstract Transcranial magnetic stimulation (TMS) has recently been approved by the Food and Drug Administration for treatment of depression refractory to at least 1 antidepressant medication. Clinical psychiatrists as well as patients are likely to inquire about TMS as a therapeutic option for the depressed patient. In particular, as TMS is a procedure that has at least some superficial similarities to electroconvulsive therapy (ECT), there will be interest in using TMS as a possible alternative to ECT. On the other hand, ECT has been in use for many decades and has a well-established track record of being the most effective treatment for depression. In this article, the author reviews the efficacy, adverse effect profile, cost, and inconvenience issues for both TMS and ECT and outlines some considerations for current clinical decision making regarding the choice between these 2 modalities. © 2011 Lippincott Williams & Wilkins, Inc.